Bioxytran, Inc financial data

Symbol
BIXT on OTC
Location
C/O Bioxytran, Inc., 75 2 Nd Ave, Suite 605 Ste 605, Needham, MA
State of incorporation
Nevada
Fiscal year end
December 31
Former names
U.S. RARE EARTH MINERALS, INC. (to 10/30/2018), U.S. RARE EARTH MINERALS, INC (to 10/3/2018), U.S. Natural Nutrients & Minerals, Inc. (to 4/14/2011), AMERICA'S DRIVING RANGES, INC. (to 10/29/2009)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.64 % -74.1%
Debt-to-equity -116 % +3.68%
Return On Equity 191 % +89.9%
Return On Assets -2.42K % -129%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 178M shares +34.3%
Common Stock, Shares, Outstanding 177M shares +34.4%
Entity Public Float 9.2M USD -11.4%
Common Stock, Value, Issued 177K USD +34.4%
Weighted Average Number of Shares Outstanding, Basic 177M shares +37.1%
Weighted Average Number of Shares Outstanding, Diluted 177M shares +37.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.04M USD +18.3%
General and Administrative Expense 2.16M USD +88.8%
Operating Income (Loss) -3.41M USD -31.7%
Nonoperating Income (Expense) -174K USD +76.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.58M USD -7.63%
Net Income (Loss) Attributable to Parent -3.51M USD -11%
Earnings Per Share, Basic -0.01 USD/shares +50%
Earnings Per Share, Diluted -0.01 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 13.5K USD -70.1%
Intangible Assets, Net (Excluding Goodwill) 68.3K USD +261%
Assets 129K USD -10.1%
Accounts Payable, Current 201K USD
Liabilities, Current 1.23M USD -55.6%
Liabilities 1.23M USD -55.6%
Retained Earnings (Accumulated Deficit) -17M USD -26.4%
Stockholders' Equity Attributable to Parent -4.76M USD -264%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.1M USD +58.7%
Liabilities and Equity 129K USD -10.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.6K USD +59.6%
Net Cash Provided by (Used in) Financing Activities 65.5K USD +31%
Net Cash Provided by (Used in) Investing Activities -6K USD -27.3%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 177M shares +34.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 52.4K USD
Deferred Tax Assets, Valuation Allowance 2.84M USD +45.8%
Deferred Tax Assets, Gross 2.84M USD +45.8%
Deferred Tax Assets, Operating Loss Carryforwards 13.5M USD +45.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 16.4M USD +45.2%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets 9.15K USD +102%
Interest Expense 1.98M USD +99.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%